An area of life sciences, proteomics is the study of protein sets in a biological context, with the field playing a key role in precision medicine, detecting pathogens and the development of new pharmaceutical treatments.
The AOHUPO congress in Melbourne is expected to draw more than 400 delegates and inject $1.8 million into the Victorian economy.
The bid for the conference was won through a collaboration between Melbourne Convention Bureau (MCB) and the Australian Proteomics Society (APS).
“Proteomics is transforming our ability to understand disease at the molecular level,” said Australian Proteomics Society president, Professor Anthony W. Purcell.
“AOHUPO 2027 will bring together researchers from across Asia and Oceania to share advances, build new collaborations and apply these technologies to regional challenges in human disease and precision medicine.”
Australian Proteomics Society vice president, Associate Professor Melanie White, said Australia had a long-standing reputation as a world leader in proteomics.
“As host of AOHUPO 2027, Australia will showcase its world-class research and innovation to the Asia-Pacific region, bringing together leading scientists, clinical scientists and industry partners to address today’s most pressing challenges and shape the future of proteomics and beyond,” she said.
Meanwhile, AUHUPO treasurer and the meeting’s co-convenor, Professor Mark Molloy, said the 2027 congress was an “exciting opportunity to grow connections amongst proteomic researchers in the Asia Oceania region”.
“Together we can work towards solving some of the challenges facing the world, with a focus on our region,” said Molloy.
Both Victoria’s major events minister, Steve Dimopoulos, and MCB’s chief executive, Julia Swanson, noted the positive impact hosting the conference would have on Melbourne’s intellectual profile.
